Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Mar 3;18(3):808–815. doi: 10.1158/1055-9965.EPI-08-0784

Table 3.

Projected effect of increasing obesity on grade-specific prostate cancer incidence and overall mortality among men ages 40–75 y in 2002

Effect on incidence per 100,000 men
Ages (y) Low grade
High grade
Observed Projected Observed Projected
40–44 7.7 7.8 1.0 0.9 0.8 12.0
45–49 37.1 37.4 0.9 5.5 5.0 11.1
50–54 131.5 132.8 0.9 23.7 21.3 11.1
55–59 324.3 329.4 1.5 58.3 50.0 16.6
60–64 522.8 531.0 1.5 101.6 87.1 16.6
65–69 783.7 793.6 1.3 173.2 149.8 15.6
70–74 884.5 895.7 1.3 212.2 183.5 15.6
Adjusted 277.1 280.8 1.3 57.8 50.1 15.5
Effect on mortality per 100,000 men
Ages (y) Observed Projected
General BMI-specific

40–44 0.2 0.2 11.1 0.1 58.1
45–49 0.8 0.7 7.5 0.6 28.2
50–54 2.4 2.2 8.2 1.9 25.6
55–59 7.3 6.7 9.1 5.3 37.1
60–64 21.2 19.5 8.5 17.1 23.7
65–69 47.0 43.4 8.4 38.5 22.2
70–74 102.1 96.7 5.6 84.1 21.5
Adjusted 16.9 15.8 7.0 13.7 23.0

NOTE: Projected incidence rates assume constant 1980 obesity prevalence rates and are based on relative risks re-estimated using PCPT data. Projected mortality rates use projected incidence and selected cause-specific and other-cause survival hazard ratios for obese men. General survival uses hazard ratios hpc = hoc = 1 for obese men, whereas BMI-specific survival uses hpc = 2.64 and ( h1oc,h2oc,h3oc) = (1.4, 1.2, 1.1) for obese men in age groups 40–54, 55–64, and 65–74 y.